Aesthetic medicine products. Good Glamm Group raises US$150 million in Series D funding round

Derma filler

THE WHAT? MyGlamm parent company Good Glamm Group has raised US$150 million in a Series D funding round, including both primary and secondary capital. 

THE DETAILS The round was co-led by marquee tech and private equity investors Prosus Ventures, Warburg Pincus, with participation from Alteria Capital and existing investors L’Occitane, Bessemer Venture Partners, Amazon, Ascent Capital, Stride Ventures and the Mankekar Family Office.

Fat dissolving

The funding sees the Good Glamm Group become India’s first DTC beauty and personal care company to reach Unicorn status.

THE WHY? The group will be using the latest funding to invest in product development, support data science and technology research, increase offline expansion, fund working capital requirements as well as expanding the content creation capabilities and digital reach of POPxo, Plixxo, BabyChakra and ScoopWhoop.

Darpan Sanghvi, Group Founder & CEO, Good Glamm Group, says, “Entering the Unicorn Club marks Day 1 for all of us at the Good Glamm Group. And we couldn’t be more excited and privileged to embark on the journey from 1 to 10, with Prosus and Warburg, who bring incredible strength and experience to our company. (sic)”

Aesthetic medicine products are developed and regulated to meet stringent safety and efficacy standards. They are typically administered by trained healthcare professionals such as dermatologists, plastic surgeons, and specialized nurses in clinical settings. These products aim to provide effective solutions for cosmetic enhancement, skin rejuvenation, and overall aesthetic improvement, contributing to both physical appearance and self-confidence.

Key categories of aesthetic medicine products include:

  • Injectables: This category includes products such as dermal fillers, botulinum toxins (e.g., Botox), and collagen stimulators. These injectables are used to smooth wrinkles, add volume, and improve facial contours.

  • Skin Rejuvenation Treatments: Products like chemical peels, microdermabrasion systems, and laser devices are used to improve skin texture, reduce pigmentation irregularities, and enhance overall skin tone.

  • Skincare Products: These include medical-grade cleansers, moisturizers, serums, and topical treatments containing active ingredients like retinoids, antioxidants, and growth factors. They are formulated to address specific skin concerns such as acne, aging, and hyperpigmentation.

  • Hair Restoration Products: Medical treatments and products designed to promote hair growth and treat conditions such as male and female pattern baldness.

  • Body Contouring and Fat Reduction: Devices and products used for non-surgical body sculpting, such as cryolipolysis (cool sculpting) devices and injectable lipolytics.

  • Cosmeceuticals: High-performance skincare products that bridge the gap between cosmetics and pharmaceuticals, often containing potent ingredients with proven clinical benefits.

  • Wound Care and Scar Management: Products like silicone sheets, gels, and advanced wound dressings used to improve healing and reduce the appearance of scars.

  Aesthetic medicine products. NTWRK raises US$50 million